Dr. Nester is a NIH-funded, tenured faculty member with a translational research program focusing on rare complement-mediated kidney diseases - including aHUS and C3G. She is the primary investigator for the University of Iowa’s C3 Glomerulopathy Natural History Study, which includes one of the largest cohorts of patients with rare C3 Glomerulopathy available to research. Finally, Dr Nester is a clinical trialist.  Her Internal Medicine and Pediatric clinical practice has become a hub for bringing the new generation of anticomplement therapeutics to a rare disease population.